Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kerry Lenzi"'
Autor:
Mihir Kakara, Dina A. Jacobs, Scott E. Hensley, Diego A. Espinoza, Kerry Lenzi, Ayman Rezk, Paul Bates, Ina Mexhitaj, Michael R. Betts, Daniel M. Markowitz, E. John Wherry, Kristina R. Patterson, Divij Mathew, Daniela Weiskopf, Sigrid Gouma, Allison R. Greenplate, Rishi R. Goel, Eline T. Luning Prak, Jessy C. Kadri, Amit Bar-Or, Alessandro Sette, Kendall A. Lundgreen, Sokratis A. Apostolidis, Alba Grifoni, Rui Li, Clyde E. Markowitz, Allison Babb, Mark M Painter
Publikováno v:
Nature Medicine
SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced responses in immunosuppressed patients. We investigated induction of antigen-spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858b747b8ca85e090edffbb5cc244652
https://doi.org/10.1038/s41591-021-01507-2
https://doi.org/10.1038/s41591-021-01507-2
Autor:
Keith W Hamilton, Kathleen Degnan, Melissa White, Lauren Dutcher, Shawn Binkley, Kerry Lenzi, Christo Cimino, Stephen Saw, Vasilios Athans, Steven Morgan
Publikováno v:
Open Forum Infectious Diseases
Background The Clinical and Laboratory Standards Institute reduced the levofloxacin minimum inhibitory concentration (MIC) breakpoint from ≤2 to ≤0.5 mg/L for Enterobacteriaceae in 2019 guidelines. The reduction is based on Monte Carlo simulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de1430a851cf2ccacfce2cccbbf2e5ea
https://doi.org/10.1093/ofid/ofz360.199
https://doi.org/10.1093/ofid/ofz360.199